Notice: This company has been marked as potentially delisted and may not be actively trading. Idera Pharmaceuticals (IDRA) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Ekso Bionics (NASDAQ: EKSO)April 11, 2024 | fool.comKiniksa PharmaceuticalsNovember 15, 2023 | forbes.comNabriva Therapeutics AG (NBRVF)August 9, 2023 | investing.comMarginaliaApril 26, 2023 | npr.orgA mysterious rift propels the story in ‘Take What You Need’March 17, 2023 | washingtonpost.comIdera Pharmaceuticals, Inc.: Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookJanuary 18, 2023 | finanznachrichten.deIdera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookJanuary 17, 2023 | finance.yahoo.comWhy Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionJanuary 10, 2023 | msn.comIdera (IDRA) Stock Soars on GlaxoSmithKline PartnershipJanuary 4, 2023 | thestreet.comIdera Pharmaceuticals, Inc.: Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 18, 2022 | finanznachrichten.deIdera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 14, 2022 | finance.yahoo.comIdera Pharma Acquires Rare Disease Player, Names New CEOSeptember 29, 2022 | finance.yahoo.comIdera Pharma Shares Rise Nearly 18% After Aceragen AcquisitionSeptember 28, 2022 | marketwatch.comIdera Pharmaceuticals Acquires AceragenSeptember 28, 2022 | finance.yahoo.comIdera Pharmaceuticals Stock (NASDAQ:IDRA), DividendsSeptember 27, 2022 | benzinga.comIdera Pharmaceuticals Reports Second Quarter 2022 Financial ResultsAugust 9, 2022 | finance.yahoo.comIdera halts melanoma trial for cancer candidate after early positive resultsMay 17, 2022 | seekingalpha.comWhy Are Idera Pharmaceuticals Shares Soaring TodayMay 17, 2022 | finance.yahoo.comIdera Pharmaceuticals Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMCMay 17, 2022 | finance.yahoo.comIdera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateMay 5, 2022 | finance.yahoo.comIdera Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate UpdateMarch 31, 2022 | finance.yahoo.comIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) Sees Large Increase in Short InterestIdera Pharmaceuticals, Inc. (NASDAQ:IDRA) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 1,140,000 shares, an increase of 588.0% from the November 30th total of 165,700 shares. Based on an average trading volume of 1,010,000 shares, the short-interest ratio is currently 1.1 days. Approximately 2.8% of the shares of the company are short sold.January 3, 2022 | marketbeat.comIdera Shares Fall After Early Tilsotolimod Data, Seeks Collaborating Partners For TLR9 AgonistDecember 15, 2021 | msn.comIdera Pharmaceuticals Announces Tilsotolimod UpdatesDecember 14, 2021 | finance.yahoo.com5 Penny Stocks To Buy According To Analysts & Targets Up To 341%December 8, 2021 | chron.comIdera Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateNovember 8, 2021 | finance.yahoo.comIdera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate UpdateAugust 9, 2021 | finance.yahoo.com Get Idera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide IDRA Media Mentions By Week IDRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDRA News Sentiment▼0.000.47▲Average Medical News Sentiment IDRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDRA Articles This Week▼00▲IDRA Articles Average Week Get Idera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IDRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Champions Oncology News Today Tarsus Pharmaceuticals News Today Recursion Pharmaceuticals News Today Immunocore News Today Neumora Therapeutics News Today BioCryst Pharmaceuticals News Today Novavax News Today Mesoblast News Today LENZ Therapeutics News Today Immatics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDRA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Idera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Idera Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
